ID
24989
Descripción
Study ID: 101468/166 Clinical Study ID: SKF-101468/166 Study Title: A Phase II, randomised, double-blind, active-controlled, dose-escalation study to determine the maximum well-tolerated starting dose of a new formulation of ropinirole in Parkinson's Disease patients not receiving other dopaminergic therapies Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Parkinson Disease
Palabras clave
Versiones (2)
- 2017-08-23 2017-08-23 -
- 2017-09-04 2017-09-04 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
23 augusti 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
study drug compliance determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166
study drug compliance determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166
Descripción
Number of Visit
Alias
- UMLS CUI-1
- C1549755
Descripción
Return of unused study drugs
Alias
- UMLS CUI-1
- C2699071
Descripción
Regimen: prescribed number of tablets per day
Alias
- UMLS CUI-1
- C3166216
- UMLS CUI-2
- C0039225
- UMLS CUI-3
- C0237753
Descripción
number of tablets
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Descripción
number of tablets
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Descripción
number of tablets
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Descripción
only for patients in Cohort E, all others mark "NA"
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Descripción
Total number of tablets dispensed at last visit
Alias
- UMLS CUI-1
- C0805077
- UMLS CUI-2
- C0304229
Descripción
number of tablets
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Descripción
number of tablets
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Descripción
number of tablets
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Descripción
only for patients in Cohort E, all others mark "NA"
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Descripción
Total number of tablets returned at this visit
Alias
- UMLS CUI-1
- C0993159
- UMLS CUI-2
- C2699071
Descripción
number of tablets
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Descripción
number of tablets
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Descripción
number of tablets
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Descripción
only for patients in Cohort E, all others mark "NA"
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Descripción
Number of tablets taken by the patient (according to the diary card)
Alias
- UMLS CUI-1
- C1290952
Descripción
number of tablets
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Descripción
number of tablets
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Descripción
number of tablets
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Descripción
only for patients in Cohort E, all others mark "NA"
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Descripción
TOTAL Number of tablets taken - all bottles
Alias
- UMLS CUI-1
- C0039225
- UMLS CUI-2
- C0237753
- UMLS CUI-3
- C1883727
Descripción
TOTAL Number of tablets patient should have taken ( assuming 100% compliance)
Alias
- UMLS CUI-1
- C0039225
- UMLS CUI-2
- C0237753
- UMLS CUI-3
- C1883727
Descripción
Patient's Compliance
Alias
- UMLS CUI-1
- C1321605
Descripción
Tablet Count
Alias
- UMLS CUI-1
- C0039225
- UMLS CUI-2
- C0237753
Descripción
If "No", explain below.
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
- UMLS CUI [1,3]
- C0205197
Descripción
If No, please explain
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
- UMLS CUI [1,3]
- C0205197
Similar models
study drug compliance determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166
C0039225 (UMLS CUI-2)
C0237753 (UMLS CUI-3)
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0304229 (UMLS CUI-2)
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C2699071 (UMLS CUI-2)
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI-2)
C1883727 (UMLS CUI-3)
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI-2)
C1883727 (UMLS CUI-3)
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
C0237753 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])